Maxwell Linda

Maxwell Linda is listed in filings as Director at ImmunityBio, Inc.. This profile follows SEC Form 4 activity through Jun 20, 2025, including 2 public disclosures. Recent filings connect the profile to ImmunityBio, Inc. (IBRX). The current snapshot covers public activity from Jun 13, 2024 to Jun 20, 2025. Reported amounts are shown as $462.7K to $462.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.